Abstract:Objective We carried out a meta-analysis to quantitatively summarize the overall diagnostic and predictive effects of circulating microRNAs in diagnosis and prediction of preeclampsia, respectively. Study design We screened selected databases and systematically retrieved articles until September 20th, 2019 for analysis. After literature screening and data extraction, we firstly conducted quality assessment according to QUADAS-2 score system. And then the pooled diagnostic and predictive parameters were calculated using a bivariate random-effect meta-analysis model. We used threshold effect analysis and subgroup analysis to identify the sources of heterogeneity. The clinical utility was validated through the Fagan's Nomogram. Sensitivity analysis was performed to assess the reliability of each included study, and we evaluated publication bias with the Deeks' funnel plot asymmetry test. Results The meta-analysis included 8 articles comprising 273 preeclampsia patients and 343 normal pregnancies. Pooled results of diagnostic values of 5 articles indicated a sensitivity of 0.88 (95 %CI: 0.80−0.93), specificity of 0.87 (95 %CI: 0.78−0.92) and diagnostic odds ratio of 50.24 (95 %CI: 21.28–118.62). The pooled sensitivity, specificity, DOR of circulating microRNAs for predicting preeclampsia of asymptomatic pregnancies were 0.61 (95 %CI: 0.55−0.68), 0.78 (95 %CI: 0.72−0.83) and 5.7 (95 %CI: 3.7–8.7) across other 3 articles. Subgroup analysis revealed that non-plasma specimen type, non-U6 reference gene and non-Asian had better diagnostic value while due to limited data, we did not conduct a subgroup analysis of predictive value. Conclusions Circulating miRNAs distinguish patients with preeclampsia from controls with relatively high diagnostic and predictive accuracy. Then we conclude that circulating miRNAs could be a useful screening tool to diagnose and predict preeclampsia. However, its utility should be judged with caution and large-sample prospective studies are warranted to explore if its implementation improves maternal and neonatal outcomes.

Circulating MicroRNAs As Potential Molecular Biomarkers in Pathophysiological Evolution of Pregnancy

Integrative Analysis of Circulating Micrornas and the Placental Transcriptome in Recurrent Pregnancy Loss

MicroRNA–mRNA Networks in Pregnancy Complications: A Comprehensive Downstream Analysis of Potential Biomarkers

From Implantation to Epigenetics

Circulating Micrornas As Biomarkers for Diagnosis and Prediction of Preeclampsia: A Systematic Review and Meta-Analysis

MicroRNAs in Human Placental Development and Pregnancy Complications

Emerging role of miRNAs, lncRNAs, and circRNAs in pregnancy-associated diseases

Biomarkers and diagnostic significance of non-coding RNAs in extracellular vesicles of pathologic pregnancy

A comprehensive survey of maternal plasma miRNAs expression profiles using high-throughput sequencing.

Diagnostic role of microRNA expression profile in the serum of pregnant women with fetuses with neural tube defects.

MicroRNAs as Potential Serum Biomarkers for Early Detection of Ectopic Pregnancy

INVESTIGATION OF MICRORNA LEVELS IN BLOOD PLASMA IN PREGNANT WOMEN WITH GESTATIONAL ARTERIAL HYPERTENSION, PREECLAMPSIA, AND FETAL GROWTH RETARDATION SYNDROME

Clinical application of exosomes and circulating microRNAs in the diagnosis of pregnancy complications and foetal abnormalities

Placenta-Specific Circulating Mircornas and Their Variants As Potential Biomarkers for Preeclampsia

Circulating MicroRNAs as Biomarkers of Gestational Diabetes Mellitus: Updates and Perspectives

MicroRNA Biomarkers for Early Detection of Embryonic Malformations in Pregnancy

Circulating extracellular vesicular microRNA signatures in early gestation show an association with subsequent clinical features of pre-eclampsia

Application of Next-Generation Sequencing Technology to Profile the Circulating Micrornas in the Serum of Preeclampsia Versus Normal Pregnant Women

Placenta-Derived MicroRNAs in the Pathophysiology of Human Pregnancy

MicroRNAs as Biomarkers and Therapeutic Targets in Female Infertility

The Study Advancement of the MicroRNAs and Obstetric Pathologies